Todd W. Butler

1.7k total citations
23 papers, 1.1k citations indexed

About

Todd W. Butler is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Todd W. Butler has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 12 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Todd W. Butler's work include Neuroscience and Neuropharmacology Research (5 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Fluorine in Organic Chemistry (4 papers). Todd W. Butler is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Fluorine in Organic Chemistry (4 papers). Todd W. Butler collaborates with scholars based in United States and United Kingdom. Todd W. Butler's co-authors include B. L. CHENARD, Carol B. Fox, Ismail A. Shalaby, Christopher W. am Ende, James F. Blake, Mary Collins, Leslie K. Chambers, Nicholas D. Ball, B. Kenneth Koe and J. Bordner and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Todd W. Butler

23 papers receiving 1.1k citations

Peers

Countries citing papers authored by Todd W. Butler

Since Specialization

Citations

This map shows the geographic impact of Todd W. Butler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd W. Butler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd W. Butler more than expected).

Fields of papers citing papers by Todd W. Butler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd W. Butler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd W. Butler. The network helps show where Todd W. Butler may publish in the future.

Co-authorship network of co-authors of Todd W. Butler

This figure shows the co-authorship network connecting the top 25 collaborators of Todd W. Butler. A scholar is included among the top collaborators of Todd W. Butler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd W. Butler. Todd W. Butler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sulfur(vi) fluorides as tools in biomolecular and medicinal chemistry 2023 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), Jisun Lee, Todd W. Butler, Jaimeen D. Majmudar, Christopher W. am Ende, Nicholas D. Ball	52
2	Fluorophosphonates on‐Demand: A General and Simplified Approach toward Fluorophosphonate Synthesis 2021 ·ChemBioChem ·Jason K. Dutra, Timothy L. Foley, Zhen Huang, Ethan L. Fisher, Erik LaChapelle, Subham Mahapatra, Kevin Ogilvie, Todd W. Butler, Justin Bellenger, Jaimeen D. Majmudar, Christopher W. am Ende	5
3	SuFEx Activation with Ca(NTf ₂ ) ₂ : A Unified Strategy to Access Sulfamides, Sulfamates, and Sulfonamides from S(VI) Fluorides 2020 ·Organic Letters ·Subham Mahapatra, (unknown), Todd W. Butler, (unknown), (unknown), (unknown), (unknown), Jason K. Dutra, Beth C. Vetelino, Justin Bellenger, Christopher W. am Ende, Nicholas D. Ball	113
4	Preparation of Carbamates, Esters, Amides, and Unsymmetrical Ureas via Brønsted Acid-Activated N-Acyl Imidazoliums 2020 ·Organic Process Research & Development ·(unknown), Todd W. Butler, (unknown)	11
5	Introduction of a Crystalline, Shelf-Stable Reagent for the Synthesis of Sulfur(VI) Fluorides 2018 ·Organic Letters ·(unknown), Paramita Mukherjee, Rongqiang Liu, Edelweiss Evrard, (unknown), John M. Humphrey, Todd W. Butler, Lise R. Hoth, Jeffrey B. Sperry, Sylvie K. Sakata, Christopher J. Helal, Christopher W. am Ende	112
6	Casein Kinase 1δ/ε Inhibitor PF-5006739 Attenuates Opioid Drug-Seeking Behavior 2014 ·ACS Chemical Neuroscience ·Travis T. Wager, Ramalakshmi Y. Chandrasekaran, Jenifer A. Bradley, David M. Rubitski, (unknown), Scot Mente, Todd W. Butler, Angela C. Doran, Cheng Chang, Katherine Fisher, John D. Knafels, Shenping Liu, Jeffrey F. Ohren, M. Marconi, George J. DeMarco, Blossom Sneed, Kevin M. Walton, (unknown), (unknown), Andy Mead	29
7	Metabolism, Distribution and Excretion of a Selective N-Methyl-d-Aspartate Receptor Antagonist, Traxoprodil, in Rats and Dogs 2007 ·Drug Metabolism and Disposition ·Chandra Prakash, Donghui Cui, Michael J. Potchoiba, Todd W. Butler	8
8	Quinazolin-4-one α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonists: Structure−Activity Relationship of the C-2 Side Chain Tether 2001 ·Journal of Medicinal Chemistry ·Bertrand L. Chenard, Willard M. Welch, James F. Blake, Todd W. Butler, (unknown), Frank E. Ewing, Frank S. Menniti, Martin J. Pagnozzi	37
9	(3R,4S)-3-[4-(4-Fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: A Conformationally Restricted Analogue of the NR2B Subtype-Selective NMDA Antagonist (1S,2S)-1-(4-Hydroxyphenyl)-2- (4-hydroxy-4-phenylpiperidino)-1-propanol 1998 ·Journal of Medicinal Chemistry ·Todd W. Butler, James F. Blake, Jon Bordner, Paul Butler, Bertrand L. Chenard, Mary Collins, (unknown), (unknown), (unknown), Frank S. Menniti, Martin J. Pagnozzi, Steven B. Sands, (unknown), Walter A. Volberg, William F. White, Dayao Zhao	26
10	Synthesis of high-specific activity tritium and optically pure [14C]CP-101,606. Enantioselective crystallization of a radiochemically racemic mixture 1997 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Keith E. McCarthy, Steve Miller, B. L. CHENARD, Todd W. Butler, (unknown), (unknown)	3
11	5,7-Dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: A Potent and Centrally-Selective Inhibitor of Acetylcholinesterase 1995 ·Journal of Medicinal Chemistry ·(unknown), Todd W. Butler, Douglas S. Chapin, (unknown), (unknown), Jeffrey L. Ives, Susan B. Jones, Dane Liston, A. Nagel	36
12	(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses 1995 ·Journal of Medicinal Chemistry ·B. L. CHENARD, J. Bordner, Todd W. Butler, Leslie K. Chambers, Mary Collins, (unknown), (unknown), (unknown), Carol B. Fox	150
13	ChemInform Abstract: 5,7‐Dihydro‐3‐(2‐(1‐(phenylmethyl)‐4‐piperidinyl)ethyl)‐6H‐pyrrolo(3,2‐ f)‐1,2‐benzisoxazol‐6‐one: A Potent and Centrally‐Selective Inhibitor of Acetylcholinesterase with an Improved Margin of Safety. 1995 ·ChemInform ·(unknown), Todd W. Butler, Douglas S. Chapin, (unknown), (unknown), Jeffrey L. Ives, Shawn B. Jones, Dane Liston, A. Nagel, Deane M. Nason, J.A. Nielsen, Antonio Ramı́rez, Ismail A. Shalaby, William F. White	3
14	ChemInform Abstract: (1S,2S)‐1‐(4‐Hydroxyphenyl)‐2‐(4‐hydroxy‐4‐phenylpiperidino)‐1‐ propanol: A Potent New Neuroprotectant Which Blocks N‐Methyl‐D‐ aspartate Responses. 1995 ·ChemInform ·B. L. CHENARD, Jon Bordner, Todd W. Butler, Leslie K. Chambers, Mary Collins, (unknown), (unknown), (unknown), Carol B. Fox, E. Edward Mena, Frank S. Menniti, J.A. Nielsen, Martin J. Pagnozzi, K. Richter, (unknown), Ismail A. Shalaby, (unknown), William F. White	20
15	Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase 1994 ·Journal of Medicinal Chemistry ·Anabella Villalobos, James F. Blake, Christopher K. Bíggers, Todd W. Butler, Douglas S. Chapin, Yuhpyng L. Chen, Jeffrey L. Ives, Shawn B. Jones, Dane Liston	92
16	Electronic structure calculations of 1,3‐dipolar cycloadditions using density functional and Hartree–Fock methods 1994 ·International Journal of Quantum Chemistry ·Carlos Sosa, Jan Andzelm, (unknown), James F. Blake, B. L. CHENARD, Todd W. Butler	35
17	Oxindole N-Methyl-D-Aspartate (NMDA) antagonists 1993 ·Bioorganic & Medicinal Chemistry Letters ·B. L. CHENARD, Todd W. Butler, Ismail A. Shalaby, (unknown), B. Kenneth Koe, Carol B. Fox	4
18	Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Ismail A. Shalaby, B. L. CHENARD, (unknown), Todd W. Butler	54
19	Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds 1991 ·Journal of Medicinal Chemistry ·B. L. CHENARD, Ismail A. Shalaby, B. Kenneth Koe, (unknown), Todd W. Butler, (unknown), Anne W. Schmidt, Carol B. Fox	130
20	A unified approach to systematic isosteric substitution for acidic groups and application to NMDA antagonists related to 2-amino-7-phosphonoheptanoate 1990 ·Journal of Medicinal Chemistry ·B. L. CHENARD, Christopher A. Lipinski, Beryl W. Dominy, E. Edward Mena, (unknown), (unknown), (unknown), Martin J. Pagnozzi, Todd W. Butler, Terence Tsang	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact